Emma Woolner

Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**

The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19

Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases

Coronavirus biology and replication: implications for SARS-CoV-2

Development of vaccines and antivirals for combating viral pandemics

Impact of COVID-19 pandemic on mental health in the general population: A systematic review

A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Dictionary learning for integrative, multimodal and scalable single-cell analysis

When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19

Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency